Vicplas International Ltd
SGX:569
Relative Value
The Relative Value of one Vicplas International Ltd stock under the Base Case scenario is 0.206 SGD. Compared to the current market price of 0.115 SGD, Vicplas International Ltd is Undervalued by 44%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Valuation Multiples
Multiples Across Competitors
Competitors Multiples
Vicplas International Ltd Competitors
Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
---|---|---|---|---|---|---|---|---|
SG |
Vicplas International Ltd
SGX:569
|
58.8m SGD | 0.5 | 30 | 7.9 | 23.2 | ||
US |
Abbott Laboratories
NYSE:ABT
|
183.6B USD | 4.6 | 32.6 | 19.2 | 28.6 | ||
US |
Intuitive Surgical Inc
NASDAQ:ISRG
|
135.3B USD | 18.5 | 68.1 | 55.8 | 70 | ||
US |
Stryker Corp
NYSE:SYK
|
125.1B USD | 6 | 37.2 | 24.2 | 29.7 | ||
IE |
Medtronic PLC
NYSE:MDT
|
108.6B USD | 3.4 | 25.9 | 13.8 | 19.5 | ||
US |
Boston Scientific Corp
NYSE:BSX
|
106.8B USD | 7.3 | 60.5 | 30.8 | 45.5 | ||
US |
Becton Dickinson and Co
NYSE:BDX
|
67.8B USD | 3.5 | 55.6 | 18.6 | 39.4 | ||
DE |
Siemens Healthineers AG
XETRA:SHL
|
58.6B EUR | 2.7 | 38.6 | 18.5 | 31.2 | ||
CN |
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
|
379.2B CNY | 11 | 33.4 | 29.1 | 29.1 | ||
US |
Edwards Lifesciences Corp
NYSE:EW
|
51.3B USD | 8.4 | 36.3 | 26.4 | 28.5 | ||
US |
Dexcom Inc
NASDAQ:DXCM
|
50.8B USD | 13.4 | 79.5 | 59.5 | 77.4 |